29 Arts and Literature positions at UNIVERSITY OF SOUTHAMPTON in United-States in United Kingdom
-
software, and (ii) improve the transparency, facilitate result reproducibility, and encouraging the citation of research software in academic literature. About you We are seeking a researcher to contribute
-
23 Mar 2024 Job Information Organisation/Company UNIVERSITY OF SOUTHAMPTON Research Field Arts Researcher Profile Recognised Researcher (R2) First Stage Researcher (R1) Country United Kingdom
-
research team. You will have the opportunity to research the state of the art, help to design world leading novel mixed reality games, work with creatives and technical experts to make those games a reality
-
ethics and research governance applications, carrying out literature reviewing using scoping review methodology survey and qualitative data collection and analysis collaborating with professionals and
-
Research Infrastructure? No Offer Description Faculty Central (Arts and Humanities) Location: Other Salary: £44,263 to £56,021 Per annum Full Time Permanent Closing Date: Monday 13 May 2024 Interview
-
at our lively Highfield campus, you will have access to state-of-the-art teaching and research facilities, as well as our sports complex, Hartley Library and Staff Social Centre. Having secured a £300m
-
Closing Date: Monday 03 June 2024 Interview Date: To be confirmed Reference: 2720624AR Introduction Southampton Institute for Arts and Humanities (SIAH) supports a wide-range of socially engaged
-
at the University of Southampton, working towards delivering new science with the state-of-the-art Vera C. Rubin Observatory Legacy Survey of Space Time (LSST) and the Time Domain Extragalactic Survey (TiDES
-
solid-state NMR. The position will be based in the School of Biolgical Sciences, which provides state of the art facilities for invertebrate research and solid-state NMR research (both locally and through
-
modelling and, crucially, onto first-in-human clinical trials and beyond. The centre houses world-class research facilities, including state-of-the-art scientific laboratories and a clinical trials unit. The